Groundbreaking study reveals unique genetic signature of pancreatic cancer in Puerto Rican Hispanics, enabling more precise and effective treatments.
Discover how epigenetic silencing of TMEM240 drives metastatic progression in pancreatic cancer and the promising cfDNA biomarker for monitoring disease spread.
Discover how multi-cancer early detection tests using DNA methylation are revolutionizing pancreatic cancer diagnosis through simple blood tests.
Discover how BMI1 protein regulates Kras-driven transcription factor networks in early pancreatic neoplasia and opens new avenues for cancer intervention.
A groundbreaking approach in pancreatic cancer treatment harnessing cellular senescence to reactivate immune cells, particularly natural killer cells.
Exploring the promising connection between metabolic optimization and epigenetic therapy for treating resistant pancreatic cancer
Discover how HDAC inhibitors are rewiring pancreatic cancer at both nuclear and cytoplasmic levels, offering new hope for treatment.